Evidence map›Paper›PMID 38638883›Full record

ArticleFrontiers in cardiovascular medicine2024

Prevalence and outcomes of atrial fibrillation in patients suffering prostate cancer: a national analysis in the United States.

Zhemin Pan, Xiao Xu, Xi Xu, Shengyong Wu, Zhensheng Zhang, Suxuan Liu, Zhijian Liu, Boxiang Tu, Chenxin Chen, Yingyi Qin and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Zhemin PanTongji University School of Medicine, Shanghai, China.
Xiao XuTongji University School of Medicine, Shanghai, China.
Xi XuDepartment of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
Shengyong WuDepartment of Military Health Statistics, Naval Medical University, Shanghai, China.
Zhensheng ZhangDepartment of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
Suxuan LiuDepartment of Cardiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Zhijian LiuDepartment of Nursing, The 940 Hospital of Joint Logistic Support Force of PLA, Lanzhou, China.
Boxiang TuDepartment of Military Health Statistics, Naval Medical University, Shanghai, China.
Chenxin ChenDepartment of Military Health Statistics, Naval Medical University, Shanghai, China.
Yingyi QinDepartment of Military Health Statistics, Naval Medical University, Shanghai, China.
Jia HeTongji University School of Medicine, Shanghai, China.
Second Military Medical University · CNTongji University · CNChanghai Hospital · CNPeople's Liberation Army 401 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Although the adverse effects of atrial fibrillation (AF) on cancers have been well reported, the relationship between the AF and the adverse outcomes in prostate cancer (PC) remains inconclusive. This study aimed to explore the prevalence of AF and evaluate the relationship between AF and clinical outcomes in PC patients. Methods: Patients diagnosed with PC between 2008 and 2017 were identified from the National Inpatient Sample database. The trends in AF prevalence were compared among PC patients and their subgroups. Multivariable regression models were used to assess the associations between AF and in-hospital mortality, length of hospital stay, total cost, and other clinical outcomes. Results: 256,239 PC hospitalizations were identified; 41,356 (83.8%) had no AF and 214,883 (16.2%) had AF. AF prevalence increased from 14.0% in 2008 to 20.1% in 2017 ( Conclusions: The prevalence of AF among inpatients with PC increased from 2008 to 2017. AF was associated with poor prognosis and higher health resource utilization. Better management strategies for patients with comorbid PC and AF, particularly in older individuals, are required.

Indexed as

atrial fibrillationclinical outcomesprevalenceprostate cancerrisk predicator

Identifiers

PMID38638883
PMCPMC11025351
OpenAlexW4393933807

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.